Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Robson

Showing results (141-150 of 218) with videos related to

Pageof 22
Sort By:
JAMA Oncology|November 12, 2015
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAKasmintan A Schrader, Donavan T Cheng, Vijai Joseph, et al.
The New England Journal of Medicine|May 28, 2015
Gene-panel sequencing and the prediction of breast-cancer riskDouglas F Easton, Paul D P Pharoah, Antonis C Antoniou, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2019
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncologyRoberto Salgado, David B Solit, David L Rimm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancerTiffany A Traina, Hope S Rugo, James F Caravelli, et al.
Journal of Medical Genetics|April 10, 2019
Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA reportAmanda B Spurdle, Stephanie Greville-Heygate, Antonis C Antoniou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2018
Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology StudyAnne S Reiner, Julia Sisti, Esther M John, et al.
Journal of the National Cancer Institute|July 9, 2021
Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni SyndromeOzge Ceyhan-Birsoy, Pier Selenica, M Herman Chui, et al.
BMJ Open|April 28, 2018
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
American Journal of Human Genetics|August 7, 2012
Rare de novo germline copy-number variation in testicular cancerZsofia K Stadler, Diane Esposito, Sohela Shah, et al.
Pageof 22

Showing results (141-150 of 218) with videos related to

Sort By:
Pageof 22
JAMA Oncology|November 12, 2015
Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNAKasmintan A Schrader, Donavan T Cheng, Vijai Joseph, et al.
The New England Journal of Medicine|May 28, 2015
Gene-panel sequencing and the prediction of breast-cancer riskDouglas F Easton, Paul D P Pharoah, Antonis C Antoniou, et al.
European Journal of Cancer (Oxford, England : 1990)|May 8, 2019
Addressing the dichotomy between individual and societal approaches to personalised medicine in oncologyRoberto Salgado, David B Solit, David L Rimm, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Feasibility trial of letrozole in combination with bevacizumab in patients with metastatic breast cancerTiffany A Traina, Hope S Rugo, James F Caravelli, et al.
Journal of Medical Genetics|April 10, 2019
Towards controlled terminology for reporting germline cancer susceptibility variants: an ENIGMA reportAmanda B Spurdle, Stephanie Greville-Heygate, Antonis C Antoniou, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 6, 2018
Breast Cancer Family History and Contralateral Breast Cancer Risk in Young Women: An Update From the Women's Environmental Cancer and Radiation Epidemiology StudyAnne S Reiner, Julia Sisti, Esther M John, et al.
Journal of the National Cancer Institute|July 9, 2021
Paired Tumor-Normal Sequencing Provides Insights Into the TP53-Related Cancer Spectrum in Patients With Li-Fraumeni SyndromeOzge Ceyhan-Birsoy, Pier Selenica, M Herman Chui, et al.
BMJ Open|April 28, 2018
Evaluation of a decision aid for incidental genomic results, the Genomics ADvISER: protocol for a mixed methods randomised controlled trialSalma Shickh, Marc Clausen, Chloe Mighton, et al.
Journal of the National Cancer Institute|April 5, 2017
Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation CarriersKaroline B Kuchenbaecker, Lesley McGuffog, Daniel Barrowdale, et al.
American Journal of Human Genetics|August 7, 2012
Rare de novo germline copy-number variation in testicular cancerZsofia K Stadler, Diane Esposito, Sohela Shah, et al.
Pageof 22